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Abstract
Intravenous challenge with Trypanosoma cruzi can be used to investigate the process and consequences of blood parasite
clearance in experimental Chagas disease. One hour after intravenous challenge of chronically infected mice with 56106
trypomastigotes, the liver constituted a major site of parasite accumulation, as revealed by PCR. Intact parasites and/or
parasite remnants were visualized at this time point scattered in the liver parenchyma. Moreover, at this time, many of liver-
cleared parasites were viable, as estimated by the frequency of positive cultures, which considerably diminished after 48 h.
Following clearance, the number of infiltrating cells in the hepatic tissue notably increased: initially (at 24 h) as diffuse
infiltrates affecting the whole parenchyma, and at 48 h, in the form of large focal infiltrates in both the parenchyma and
perivascular spaces. Phenotypic characterization of liver-infiltrating cells 24 h after challenge revealed an increase in Mac1+,
CD8+ and CD4+ cells, followed by natural killer (NK) cells. As evidence that liver-infiltrating CD4+ and CD8+ cells were
activated, increased frequencies of CD69+CD8+, CD69+CD4+ and CD25+CD122+CD4+ cells were observed at 24 and 48 h after
challenge, and of CD252CD122+CD4+ cells at 48 h. The major role of CD4+ cells in liver protection was suggested by data
showing a very high frequency of interferon (IFN)-c-producing CD4+ cells 24 h after challenge. In contrast, liver CD8+ cells
produced little IFN-c, even though they showed an enhanced potential for secreting this cytokine, as revealed by in vitro T
cell receptor (TCR) stimulation. Confirming the effectiveness of the liver immune response in blood parasite control during
the chronic phase of infection, no live parasites were detected in this organ 7 days after challenge.
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Introduction
A main feature of human and murine infections by Trypanosoma
cruzi, the etiological agent of Chagas disease, is the rarity of
spontaneous cure. Despite the generation of a potent anti-parasite
immune response, that allows the control of parasitemia at the end
of the acute phase, a small number of T. cruzi persists in the tissues.
From this place, and for the lifetime of the host, the parasites
occasionally gain access to the blood, where they can be detected
by indirect methods such as xenodiagnosis, hemoculture, subin-
oculation or PCR [1–3].
Non-sterile control of T. cruzi at the chronic phase of the
infection depends on humoral and cellular mechanisms. Destruc-
tion of intracellular amastigotes strongly relies in parasite-specific
CD4+ and CD8+ T cells which act by release of pro-inflammatory
cytokines and chemokines and direct cytotoxicity of infected cells
[4–7]. The clearance of extracellular trypomastigotes is optimized
by the coordinated cooperation of antibodies and phagocytes, a
process that results in efficient parasite-destruction when phago-
cytes are primed by inflammatory cytokines, notably by IFNc [8].
Thus, at the tissues, following rupture of a pseudocyst, released
trypomastigotes are opsonized by IgG and subsequently phago-
cytosed by resident macrophages and recruited monocytes and
polymorphonuclear cells [9]. At the blood, clearance of IgG-
coated tripomastigotes is supposedly mediated by resident
mononuclear phagocytes at the lung, liver and spleen [10]. This
process depends on an intact Fc portion of the IgG molecule [11],
and although shown to require the participation of C3
complement component, occurs independently of the lytic
terminal pathway [12].
Low and continuous release of trypomastigotes to the blood
(and tissues) contributes to maintain the high level anti-T. cruzi
effector activity of chronically-infected mice. Short and long-term
effects of this continuous stimulus can be mimicked in an amplified
version by intravenous (i.v.) challenge of chronic mice with live
trypomastigotes. In this respect, we previously observed that 7–12
days after i.v. challenge of chronic mice with homologous
parasites, a booster of the anti-T. cruzi effector mechanisms
occurs, with increase in anti-T. cruzi IgG2a and IgG1 serum
antibody levels, intense brief burst in the spleen IFN-c production,
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activation of B and T cells and accumulation of class II+ non-B
cells in the spleen [2]. In this work, continuing our studies on the
host-parasite interaction at the chronic phase, we analyzed the
short-term effects of an intravenous challenge with trypomasti-
gotes. Parasite clearance was shown to occur to a large extent at
the liver, an organ with an efficient resident immunity that
responds to the acute T. cruzi infection with intense inflammation
and high IFN-c production [13].
Materials and Methods
Mice
Six- to 8-week-old female C57Bl/6 mice were bred under
specific pathogen-free conditions at the Isogenic Mice Facility,
Instituto de Cieˆncias Biome´dicas, Universidade de Sa˜o Paulo,
Brazil. Experiments were carried out in accordance to the ethical
guidelines for experiments with mice, the protocols being
approved by the Health Animal Committee (CEEA) of the
University of Sa˜o Paulo.
Parasites and infection
T. cruzi from the Y strain was maintained by weekly passages in
A/J mice. C57Bl/6 mice were infected intraperitoneally (i.p.) with
diluted blood containing 1000 trypomastigote forms. Parasitemias
were determined by microscopic examination of 5 ml blood
samples obtained from the tail vein. Seven to ten months after
infection, chronic mice were challenged intravenously (i.v.) with
56106 tissue culture tripomastigotes of the Y strain obtained from
infected LLCMK2 cultures. One hour later, challenged chronic
animals or unchallenged chronic controls were sacrificed to
estimate the parasite load at the lung, liver and spleen and
immunohistochemical analysis of T. cruzi at the liver tissue.
Moreover, 24 and 48 h after challenge other mice were sacrificed
for histological examination and leukocyte population analysis at
the liver.
DNA preparation and real-time PCR for T. cruzi
quantification
Total DNA from spleen, lung and liver tissues collected from
mice at the indicated time points post-infection, were extracted
using GenomicPrep Cells and Tissue DNA Isolation kit (Amer-
sham Biosciences), following the manufacturers’ protocol. Each
real-time PCR reaction contained 40 ng genomic DNA, 0.5 mM
of T. cruzi 18S rRNA gene (AF303659) - specific primers Tc18S-F
59- TTGAATTGAGGGCCTCTAAGG-39 and Tc18S-R 59-
AAAGGTACCACTCCCGTGTTT-39. The T. cruzi quantifica-
tion reactions were performed according to the manufacturers’
instructions on an ABI Prism 7900HT system. The real-time PCR
reaction used Applied Biosystems’ Power SYBR Green PCR
Master Mix. Relative quantification, DDCt method, of specific
DNA was normalized for mouse GAPDH gene (GAPDH-F 59-
TGAAGCAGGCATCTGAGGG-39 and GAPDH-R 59-CGAA-
GGTGGAAGAGTGGGAG-39).
LIT cultures of hepatic tissue
Live T. cruzi parasites in the liver of individual chronic mice
were revealed by culture of liver tissue aliquots containing 1.6 or
0.4 mg of tissue homogenate (in quadruplicate), at 28uC, in axenic
liver infusion tryptose (LIT) medium. Cultures were screened
twice a week, for a month, for epimastigote growth. To avoid
contamination of liver samples with peripheral blood, the inferior
cava vein was sectioned above the diaphragm and the animals
connected to a KDS 200 Two-Syringe Infusion Pump (KD
Scientific, New Hope, PA) which delivered sterile phosphate-
buffered saline, for 5 min, at a flow rate of 2 ml/min, through the
left ventricle.
Histopathological analysis
Liver tissue specimens were collected and fixed in 10% formalin
(Merck, La Jolla, CA) for further processing. Paraffin-embedded
tissue sections were stained with hematoxylin-eosin and analyzed
by optical microscopy. The hepatic inflammatory infiltrates were
photographed using an image analysis system (Image Pro Plus
Media Cybernetics, Silver Spring, MD).
Immunohistochemistry
Silane-coated slides (5 mm) of paraffin-embedded liver tissues
from chronic mice or from control or chronic mice that had been
inoculated i.v., 1 h before, with 56106 culture trypomastigotes were
dewaxed and hydrated by routine methods before the antigen
retrieval procedure. Immunostaining was done by overnight
incubation at room temperature with mouse-absorbed chronic
immune rat serum anti-Y strain T. cruzi parasites. Then, the sections
were first incubated for 2 h with biotin-labeled secondary antibody
and second with the peroxidase-conjugated biotin-avidin complex
(Elite ABC kit, Vector laboratories). Finally, the peroxidase was
revealed by immersion in DAB (diaminobenzidine, Sigma). Slides
were counterstained with hematoxilin.
Isolation of intrahepatic leukocytes
Intrahepatic leukocytes were isolated as described [14]. Briefly,
after perfusion with phosphate buffer solution (PBS), the liver was
removed, a cellular suspension was prepared, treated with
collagenase 0.02% (Invitrogen, Carlsbad, CA), washed, admixed
with 40% metrizamide (Sigma) solution in PBS and gently overlaid
with RPMI 1640 medium supplemented with 1% heat-inactivated
fetal calf serum (FCS). Culture medium and supplements were
purchased from Invitrogen. After centrifugation at 1500 g and
4uC, leukocytes were harvested from the medium-metrizamide
inter-phase.
Phenotypic characterization of intrahepatic leukocyte
populations
The phenotype of intra-hepatic leukocytes was determined
using a three-color FACScalibur cytometer (Becton-Dickinson,
San Jose´, CA), after staining cells with FITC-, PE-, Cy-chrome- or
biotin-conjugated monoclonal antibodies (mAbs) to CD4 (clone
Author Summary
Chagas disease, a Latin American illness caused by the
protozoan parasite Trypanosoma cruzi, has only rare
spontaneous cure, and in most patients a small number
of parasites persists for life in the blood and tissues,
leading to chronic disorders such as cardiomyopathy. In a
murine model of chronic T. cruzi infection we observed
that the liver plays an important role in the clearance of
blood-circulating parasites. Moreover, parasite accumula-
tion in this organ is followed by their elimination, an effect
that is not immediate but seems to depend on the
recruitment of leukocytes and on the local production of
IFN-c, a cytokine known to increase the T. cruzi-killing
capacity of phagocytes. Our findings contribute to the
knowledge of T. cruzi-host interaction, showing the
participation of a non-lymphoid organ in parasite control.
In addition, they contribute to understanding the multi-
faceted role the liver plays in the immune response.
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H129.19), CD8 (clone 53-6.7), B220 (clone RA3-6B2), CD11b
(Mac-1; clone M1/70), NK1.1 (clone PK136), CD69 (clone
H1.2F3), CD25 (clone 7D4) and CD122 (clone TMb1) purchased
from PharMingen (San Diego, CA). When using biotin-conjugated
mAbs, fluorochrome-labeled streptavidin (PharMingen) was added
as a second step reagent. The number of each cell population per
liver was determined by multiplying its respective frequency
among liver leukocytes by the total number of leukocytes per liver
estimated in a Neubauer chamber.
Intracellular detection of IFN-c
Intrahepatic leukocytes were cultured overnight with Golgistop
at 37uC in a 5% CO2 atmosphere, according to the manufactur-
er’s instructions, in the presence or absence of plate-bound anti-
CD3 (10 mg/ml; clone 145-2C11) and soluble anti-CD28 (2 mg/
ml; clone 37.51) mAbs. After being washed, cells were surface
stained with FITC- or Cy-Chrome-conjugated mAbs to CD4, and
CD8. Cells were then fixed with the Cytofix/Cytoperm buffer and
incubated with PE-labeled mAb to IFN-c (XMG-1.2) diluted in
Perm/Wash buffer. The analysis was done in a FACSCalibur
cytometer. All reagents were purchased from PharMingen.
Statistical analysis
Statistical analysis was performed by ANOVA and Tukey’s
multiple comparison tests, or unpaired T test, using the GraphPad
PRISM 4 software. Differences between two groups were
considered significant at p,0.05.
Results
The liver is a major site for blood parasite clearance in
chronic mice
To study the clearance of bloodstream forms of T. cruzi, chronic
mice were inoculated i.v. with 56106 trypomastigotes. Tissue
culture forms were used because blood trypomastigotes from 7-day
infected mice are coated by IgM antibodies which could interfere
in parasite recognition by specific IgG [15].
As previously described [16], parasitaemia is not detected in T.
cruzi-infected chronic mice by direct microscopic examination.
Similarly, when chronic mice were challenged i.v. with 56106
trypomastigotes we did not detect parasites in the blood any time
after challenge. Differently, non-infected mice injected with T.
cruzi displayed high parasitemias thirty minutes after injection, and
small numbers were still be seen after 24 and 48 h (Table 1).
In chronic mice, clearance of circulating blood T. cruzi parasites
is thought to be mediated by resident mononuclear phagocytic
cells in the lung, liver and spleen. To assess the relative clearance
at these organs, the tissue parasite load of chronic mice was
evaluated by real time PCR for T. cruzi DNA before and 1 or 48 h
after challenge. In unchallenged chronic mice we were unable to
amplify T. cruzi DNA in any of the three organs (data not shown).
Meanwhile, one hour after i.v. challenge of chronic mice, the
amounts of T. cruzi DNA were sharply increased, notably in the
liver and lung and, at lower level, in the spleen (Fig. 1A). Since
PCR was done with same amounts of tissue DNA and the weight
of the liver was 6.3 times that of the lungs and 12.7 times that of
the spleen, we concluded the liver plays a major role in parasite
removal. Forty eight hours after challenge the numbers of
amplified copies of T. cruzi DNA were drastically reduced in these
organs. This represented 98% reduction for the lung, 74%
reduction for the liver and 39% reduction at the spleen.
To evaluate if parasites removed by the liver were alive, liver
fragments obtained 1 and 48 h after challenge of chronic mice
were cultured in LIT medium. Liver cultures from unchallenged
chronic mice showed no live T. cruzi (data not shown).
Meanwhile, in 1-h challenged chronic mice, parasites were
observed in 100% of cultures containing 0.4 mg of liver tissue,
the number of positive cultures being strongly reduced at 48 h of
challenge (Fig. 1B). In additional experiments, no parasite was
detected in cultures containing 1.6 mg of liver tissue from 7-day
challenged chronic mice (data not shown). Differently from liver
cultures, no parasite growth was observed by culturing 5 mL
aliquots of blood from chronic mice, before, or 1 and 48 h after
challenge, in contrast with blood cultures from challenged control
mice that yielded 100% positivity (data not shown).
To visualize the parasites at the liver parenchyma of challenged
chronic mice, the liver tissue was analyzed by immunohistochem-
istry using a mouse-absorbed rat antiserum specific for T. cruzi Y
parasites. As shown in figure 2, intact or damaged parasites were
seen uniformly distributed along the liver parenchyma of 1-h
challenged chronic mice. Contrarily, in challenged control mice
and in unchallenged chronic mice, peroxidase-positive staining
was not observed.
Analysis of intra-hepatic leukocytes in challenged chronic
mice
Histological examination of the liver tissue in chronic mice
revealed a small number of focal infiltrates in the parenchyma and
few perivascular infiltrates of discrete intensity (Figure 3A). Twenty
four hours after challenge, a moderate increase in the number of
parenchyma-scattered leukocytes, many of which grouped as tiny
foci of 5–10 cells, was observed (Figure 3B). At 48 h, the above
picture progressed to harbor a high number of parenchyma-
scattered leukocytes and large-sized focal and perivascular
infiltrates (Figure 3C). Viable or damaged amastigote nests were
not visualized in the liver of chronic mice or challenged chronic
mice, in spite that they were exhaustively sought after. In contrast
to the liver, tissue pathology at the heart or striated muscle
(quadriceps) was not modified after challenge of chronic mice (data
not shown).
To analyze the cellular composition of liver infiltrates, intra-
hepatic leukocytes from chronic mice, challenged chronic mice
and controls were characterized by flow cytometry. Total number
of intra-hepatic leukocytes were discretely increased in chronic
mice compared to control mice (11.763.66106 cells versus
7.460.46106 cells; p,0.01). At the chronic phase, B (B220+)
cells were the most numerous population, but showed no changes
in relation to control mice (Figure 4). Besides, no significant
changes were observed for Mac1+ (Mac1+CD42CD82B2202)
cells and NK (NK1.1+CD42CD82) cells. CD8+ and CD4+ cells
were significantly increased in relation to control mice, with
predominance of CD8+ cells. In consonance with the histological
Table 1. Parasitaemia in chronically infected mice after
challenge with T. cruzi.
Time after
challenge Number of parasites/ml of blood (x1024)
Chronic
unchallenged
Chronic
challenged
Non-infected
challenged
30 min n.d. n.d. 66.0643.7
24 h n.d. n.d. 1.262.5
48 h n.d. n.d. 0.560.7
n.d., not detected.
doi:10.1371/journal.pntd.0000578.t001
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analysis, a huge increase in intra-hepatic leukocytes occurred in
challenged mice (from 11.763.66106 cells in chronic mice to
35.861.16106 and 43.4611.96106 cells at 24 and 48 h after
challenge, respectively). After challenge, Mac1+ cells became the
most frequent liver leukocyte population, representing the highest
cell increase in relation to chronic mice. CD8+ and CD4+ cells
progressively increased after challenge, the CD4/CD8 ratio being
maintained as in chronic mice. In additional experiments it was
observed, for both unchallenged and challenged chronic mice, that
the Mac1+ liver population included GR-1LOW and GR-1HIGH
cells [17], where GR-1HIGH cells accounted for around one third
of Mac1+ cells, 48 h after challenge (Supplementary Figure S1).
The activation status of intra-hepatic CD4+ and CD8+ cells was
estimated by expression of CD69, an early lymphocyte activation
marker [18]. For both T cell subsets, CD69 expression was higher
in chronic mice than in control mice (Figure 4). However, when
chronic mice were challenged with trypomastigotes the frequency
of CD4+CD69+ and CD8+CD69+ cells drastically increased after
24 h, slightly declining at 48 h. Challenge-induced augments in
CD69 expression correlated with increases in the frequencies of
large cells. Thus, for CD4+ cells, the percentage of large cells
increased from 23% in chronic mice to around 60% at 24 and
48 h of challenge. For CD8+ cells, a notable increase was also
found, from 30% in chronic mice to 55% and 64% at 24 and 48 h
of challenge, respectively (Supplementary Figure S2).
Expression of the IL-2 receptor a and b chains by
intra-hepatic CD4+ cells in challenged chronic mice
To further evaluate the activation status of intra-hepatic CD4+
cells we investigated the surface expression of CD25 and CD122
molecules. The CD25 molecule constitutes the IL-2 receptor (IL-
2R) a chain, which structures the high affinity IL-2R when
associated to the b (CD122) and cc (CD132) chains, and the low
affinity IL-2R, when associated to just the cc chain [19]. In
addition, the IL-2R b chain is also used, together with the cc and
the IL-15R a chains, to structure in the IL-15R [20]. In mice,
Figure 1. Tissue parasitism in chronic mice challenged with T. cruzi trypomastigotes. Chronic mice were analyzed for tissue parasitism 1 h
and 48 h after i.v. challenge with 56106 trypomastigotes. Unchallenged chronic mice were used as controls. (A) Comparison of parasite loads in
different tissues using real-time PCR for T. cruzi DNA. Average values and standard error for each experimental group (n = 3) are represented.
Differences between groups were evaluated by unpaired T test (* p,0.05, ** p,0.0001, compared to 1 h). (B) Presence of live T. cruzi parasites in the
liver of challenged chronic mice. Parasites in liver tissue fragments of 1.6 and 0.4 mg weight were amplified by LIT culture. Results represent the
frequency of T. cruzi-positive cultures in each group of mice (quadruplicate cultures per liver; n = 3). The results are representative of two experiments.
doi:10.1371/journal.pntd.0000578.g001
Figure 2. Presence of T. cruzi parasites at the liver parenchyma of chronic mice challenged with trypomastigotes. T. cruzi-infected
chronic mice and non-infected controls were injected i.v. with 56106 culture trypomastigotes and 1 h later, the animals were sacrificed and the liver
tissue screened for the presence of parasite antigen by immunohistochemistry as described in material and methods. Unchallenged chronic mice
were included as controls. Pictures are representative of three mice in each group. Challenged control mice (A); unchallenged chronic mice (B);
challenged chronic mice (C). Bar: 20 mm.
doi:10.1371/journal.pntd.0000578.g002
Liver Response to T. cruzi Challenge
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regulatory T cells usually have a CD25+CD122LOW phenotype,
while activated/effector T cells are CD25+CD122HIGH and
memory cells display a CD252CD122HIGH phenotype [21].
In chronic mice, small fractions of liver CD4+ cells bore the
CD25+CD122+ and CD25+CD122LOW/NULL phenotypes, while
around 30% had a CD252CD122+ phenotype (Figure 5A). Twenty-
four hours after challenge, half the CD4+ cells showed a
CD25+CD122+ phenotype, the expression of the CD25 molecule
in this cell subset being notably higher than that of corresponding
cells in chronic mice. Nonetheless, after 48 h, the frequency of
CD25+CD122+CD4+ cells diminished to 30%, their level of CD25
expression being also reduced. Conversely, the frequency of
CD252CD122+CD4+ cells decreased 24 h after challenge, increas-
ing again at 48 h.
CD25+CD122+CD4+ cells in the liver of challenged mice were
predominantly blasts, both at 24 and 48 h. For the
CD252CD122+CD4+ cell subset, however, the frequency of large
cells in 24-h challenged chronic mice was considerably lower,
similar to that in chronic mice (around 30–40%), increasing to
55% by 48 h (Figure 5B).
When these data were expressed in terms of total cell
numbers in the liver, we observed that CD25+CD122+CD4+
cells notably increased 24 h after challenge, the augment being
maintained at 48 h. Differently, recruitment/differentiation of
CD252CD122+CD4+ cells was relatively delayed, a significant
increase being only observed after 48 h (Figure 5C).
IFN-c production by CD4+ and CD8+ liver cells after
challenge of chronic mice with tripomastigotes
IFN-c plays a crucial role in T cruzi infection, acting at various
levels, the optimization of macrophage trypanocidal activity being
decisive [22]. During the acute phase of experimental Chagas
disease different cell types produce IFN-c in the liver, contributing
to parasite clearance at this organ [13]. At the chronic phase of T.
cruzi infection, however, dysfunctional CD8+ cells with impaired
effector functions, inclusive deficient IFN-c production, have been
described in non-lymphoid tissues [23]. To evaluate if the intra-
hepatic CD4+ and CD8+ T cell subsets produced IFN-c after
trypomastigote challenge, we examined the ex vivo production of
this cytokine, by intracellular staining, in liver cells of chronic
mice, before and 24 or 48 h after challenge with T. cruzi.
CD4+ and CD8+ liver cells from chronic mice displayed low
frequencies of IFN-c producing cells, which were not significantly
modified after in vitro stimulation with anti-CD3/CD28 mAbs
(Figure 6A–B). Twenty-four hours after challenge, however, a
huge increase in the frequency of CD4+ cells producing IFN-c was
observed. This frequency slightly decreased at 48 h of challenge,
but, because of the augment in total CD4+ cell numbers, the
population of IFN-c producing CD4+ cells in the liver remained of
the same size at 24 h and 48 h (Figure 6B). For these cells, in vitro
stimulation with anti-CD3/CD28 mAbs did not resulted in
additional increase in the frequency of IFN-c-producing cells.
Differently from CD4+ cells, challenge of chronic mice resulted in
discrete increases in the frequency (Figure 6A) and total liver
number (Figure 6B) of IFN-c-producing CD8+ cells. However,
after in vitro stimulation with anti-CD3/CD28 mAbs, important
increases in these values were observed.
Discussion
In chronic host tissues, trypomastigotes released upon rupture of
an amastigote nest immediately bind specific IgG facilitating their
internalization by resident or recruited phagocytes [24], a process
where the production of nitric oxide and oxygen radicals by
phagocytes results in destruction of the ingested parasites [22].
Yet, the uptake of opsonized trypomastigotes by tissue phagocytes
is not totally effective as a fraction of locally-released parasites
manage to reinvade neighboring cells or make their way to the
intravascular space. Once inside blood vessels, IgG-coated
trypomastigotes are quickly cleared at the lung, liver and spleen
Figure 3. Histopathological analysis of liver in unchallenged
and challenged chronic mice. C57BL/6 mice were infected with T.
cruzi and after 8 months challenged i.v. with 56106 homologous culture
trypomastigotes. Chronic mice (A) and chronic mice, 24 h (B) or 48 h (C)
after challenge. Lesions are representative of at least 6–10 animals in
each group. Bar: 100 mm.
doi:10.1371/journal.pntd.0000578.g003
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by a mechanism that depends on the Fc portion of the IgG, but
not on the lytic complement pathway [25]. This was elegantly
shown by Umekita and Mota [11] by observing that trypomas-
tigotes injected i.v. into normal mice are rapidly cleared from the
blood following i.v. administration of immune mouse serum or
parasite-specific IgG.
In this paper, by demonstrating high levels of T. cruzi DNA in
the liver of challenged chronic mice we conclude this organ plays a
major role for the removal of blood circulating parasites in chronic
mice. Meanwhile, because trypomastigotes disappear from the
blood of chronic mice soon after i.v. inoculation, but live parasites
are still found in the liver after 48 h, we conclude the uptake of
IgG-opsonized T. cruzi by liver phagocytes is not immediately
followed by their destruction. Failure to rapidly destroy the
opsonized parasites was an unexpected finding considering the
extensively documented synergism of IFN-c and specific IgG for
macrophage killing of T. cruzi [8,24]. Since serum from chronic
C57BL/6 mice contained high levels of anti-T. cruzi IgG
antibodies (data not shown), this failure could have occurred
because of insufficient signaling of resident liver phagocytes
(Kuppfer cells) by systemic or locally-released IFN-c or other
macrophage-activating cytokines, or because of an intrinsic
resistance to priming of liver phagocytes. Independently of the
reasons behind, our results indicate that, in chronic mice, resident
liver phagocytes are not fully-optimized in their trypanocidal
activity for IgG-coated parasites.
Meanwhile, the liver trypanocidal activity seems to be increased
after recruitment of lymphocytes that produce IFN-c. This is
suggested by the absence of amastigote nests at the liver in the days
following challenge and by the absence of positive LIT cultures in
liver samples obtained from 7-day challenged chronic mice. Yet, the
possibility that T. cruzi is not destroyed at the liver, the parasitized
cells leaving this organ through the bloodstream to be destroyed
elsewhere, is remote due to the fact that LIT cultures in blood
samples were also negative. Our observation that intra-hepatic
CD4+ cells produced high levels of IFN-c 24 h after clearance
indicates that following blood parasite clearance the liver becomes an
important source of this cytokine. Moreover, because IFN-c
production was induced in CD4+ cells, but only marginally in
CD8+ cells, it is possible that following immune clearance successful
Figure 4. Phenotypic characterization of cellular infiltrates in the liver of unchallenged and challenged chronic mice. C57BL/6 mice
infected for 7–10 months with T. cruzi parasites were challenged i.v. with 56106 homologous trypomastigotes and, after 24 and 48 h, liver leukocytes
analyzed by flow cytometry. Control and chronic mice were also included. (A) Mean6SD (n = 3) of total liver numbers of B (B220+), Mac1+
(Mac1+CD42CD82B2202), NK (NK1.1+CD42CD82), CD4+ and CD8+ cells; Differences between groups were evaluated by ANOVA and Tukey’s multiple
comparison tests (* p,0.05 and ** p,0.005, compared to chronic mice). A representative experiment out of three is shown. (B) CD69 expression by
gated CD4+ and CD8+ cells. Numbers indicate the mean6SD (n = 3) of the percentage of CD69+ cells. Representative histograms of one experiment
out of two are shown.
doi:10.1371/journal.pntd.0000578.g004
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presentation of parasite antigens was predominantly achieved
through MHC class II molecules. This interpretation would imply
that most cleared parasites are retained in the phagocytic vacuole of
liver phagocytes with few of them escaping to the cytosol or invading
hepatocytes, even after 48 h. Alternatively, the low spontaneous
production of IFNc by CD8+ cells could be explained by their
commitment to cytolytic function rather than cytokine production.
Interestingly, many of the CD8+ cells in the liver of challenged
chronic mice were blasts that expressed the activation marker CD69,
and indication they had been signaled and might not be totally
quiescent. It remains to be determined whether CD8+ cell activation
had occurred through class I-peptide recognition or cytokines.
In addition to IFN-c production, CD4+ cells in the liver of
challenged chronic mice presented other signs of activation, two
thirds of the cells expressing the early activation marker CD69
[18]. Moreover half the CD4+ cells were large CD25+CD122+
Figure 5. Expression of CD25 and CD122 by CD4+ cells in the liver of chronic mice challenged with T. cruzi trypomastigotes. C57BL/6
mice infected for 7 months with T. cruzi were challenged i.v. with 56106 trypomastigotes and, after 24 and 48 h, the liver leukocytes analyzed by flow
cytometry. (A) Expression of CD25 and CD122 by CD4+ cells. Frequency of large cells (B) and total liver cell numbers (C) of CD4+ subpopulations
defined by expression of CD25 and CD122 molecules. Numbers in dot blots indicate the mean frequencies of cells in quadrants. Numbers in
histograms indicate the mean frequencies of large cells among cell subsets defined by quadrants in A. Data in C correspond to the mean6SD of total
liver cell numbers of the indicated subpopulations. A representative experiment (n = 3) of two is shown. Differences between groups were evaluated
by ANOVA and Tukey’s multiple comparison tests (* p,0.01; ** p,0.001, compared to chronic mice).
doi:10.1371/journal.pntd.0000578.g005
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Figure 6. IFN-c production by CD4+ and CD8+ liver cells after challenge of chronic mice with T. cruzi tripomastigotes. Frequency (A)
and total numbers (B) of IFNc-producing cells in gated CD4+ and CD8+ cells of unchallenged and T. cruzi-challenged chronic mice. The spontaneous
and anti-CD3/CD28-stimulated production of IFNc was evaluated 24 and 48 h after challenge. Numbers inside dot-blots represent the mean6SD
(n = 3) of IFNc-producing cell frequencies. Bars in (B) represent the mean6SD (n = 3) of IFNc-producing cell numbers per liver of mice in (A); * p,0.05;
** p,0.01; *** p,0.001 (compared to chronic mice by ANOVA and Tukey’s multiple comparison tests). # p,0.05; ## p,0.0001 (compared to
spontaneous production by unpaired T test). A representative experiment out of two is shown.
doi:10.1371/journal.pntd.0000578.g006
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cells, a phenotype of effector cells. Besides this population, the liver
of challenged mice contained CD252CD122+CD4+ cells, a
population with reduced number of blasts, which could be
memory cells that respond to IL-15 [26]. The fact that the liver
of unchallenged chronic mice contains a large number of
CD252CD122+CD4+ cells, but few CD25+CD122+CD4+ cells,
together with our observation that the level of CD25 expression in
CD25+CD122+CD4+ cells decreases after 48 h of challenge, raises
the possibility that at least part of the CD25+CD122+CD4+
population differentiates in situ to CD252CD122+CD4+ memory
cells.
In spite that the IFN-c production response to clearance seemed
to be CD4+ cell-mediated, CD8+ cells predominated in the liver of
challenged chronic mice. Diverse groups have reported, in humans
and mice, that CD8+ cells constitute the predominant lymphocyte
subset in inflammatory sites of T. cruzi-infected chronic hosts
[16,27–30]. Moreover, a large fraction of CD8+ cells in chronic
mice display an effector memory (EM) phenotype [30–32],
inasmuch as they do not spontaneously produce IFN-c and other
inflammatory cytokines, but they can do so after engaging T. cruzi-
infected targets [30]. In consequence, CD8+ cells expanded/
recruited to the liver tissue of challenged chronic mice seem to be
EM cells and not anergic or dysfunctional [23], since they could be
induced to produce IFN-c upon in vitro stimulation with anti-
CD3/CD28 mAbs. By expanding/recruiting a large number of
CD8+ EM cells, the liver of the chronic host is prepared for the
eventual colonization of non-phagocytes by trypomastigotes, a
process that seems to be of little magnitude.
From the experiments shown in this work we can extrapolate
that by clearing a large fraction of blood trypomastigotes and
recruitment of IFNc-producing effector T lymphocytes the liver
plays an important role in the control of low level parasitaemia of
chronic mice. It should be considered, however, that T. cruzi
parasites are extremely diverse, exhibiting differences, not only in
relation to tropism, but also in resistance to the immune effector
mechanisms [33,34]. Therefore, because our data derive from
experiments with Y strain parasites, a prototypic rethyculotropic
strain, additional experiments will be necessary to ascertain the
extent to which these conclusions are valid for other T. cruzi
parasites.
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in the liver of unchallenged and challenged chronic mice.
Found at: doi:10.1371/journal.pntd.0000578.s001 (0.01 MB PDF)
Figure S2 Frequency of large cells among CD4+ and CD8+ cells
in the liver of unchallenged and challenged chronic mice.
Found at: doi:10.1371/journal.pntd.0000578.s002 (0.01 MB PDF)
Acknowledgments
We extend our thanks to Bernardo Paulo Albe and Meire Ioshie Hiyane for
technical assistance.
Author Contributions
Conceived and designed the experiments: LRS TM RME RSdN LAG
CRFM CPG MRDL JM. Performed the experiments: LRS TM RME
RSdN LAG DZB CRFM. Analyzed the data: LRS RSdN LAG DZB
CRFM CPG MRDL JM. Contributed reagents/materials/analysis tools:
CPG MRDL JM. Wrote the paper: LRS MRDL JM.
References
1. Avila HA, Sigman DS, Cohen LM, Millikan RC, Simpson L (1991) Polymerase
chain reaction amplification of Trypanosoma cruzi kinetoplast minicircle DNA
isolated from whole blood lysates: diagnosis of chronic Chagas’ disease. Mol
Biochem Parasitol 48: 211–221.
2. Marinho CR, Bastos KR, Sardinha LR, Grisotto MG, Lima MR, et al. (2004)
Challenge of Trypanosoma cruzi chronically infected mice with trypomastigotes
activates the immune system and reduces subpatent parasitemia levels. J Parasitol
90: 516–523.
3. Marinho CR, Bucci DZ, Dagli ML, Bastos KR, Grisotto MG, et al. (2004)
Pathology affects different organs in two mouse strains chronically infected by a
Trypanosoma cruzi clone: a model for genetic studies of Chagas’ disease. Infect
Immun 72: 2350–2357.
4. Russo M, Starobinas N, Marcondes MC, Minoprio P, Honteyberie-Joskowicz M
(1996) The influence of T cell subsets on Trypanosoma cruzi multiplication in
different organs. Immunol Lett 49: 163–168.
5. Rottenberg ME, Bakhiet M, Olsson T, Kristensson K, Mak T, et al. (1993)
Differential susceptibilities of mice genomically deleted of CD4 and CD8 to
infections with Trypanosoma cruzi or Trypanosoma brucei. Infect Immun 61:
5129–5133.
6. Tarleton RL, Koller BH, Latour A, Postan M (1992) Susceptibility of beta 2-
microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 356:
338–340.
7. Nickell SP, Sharma D (2000) Trypanosoma cruzi: roles for perforin-dependent
and perforin-independent immune mechanisms in acute resistance. Exp
Parasitol 94: 207–216.
8. Plata F, Wietzerbin J, Pons FG, Falcoff E, Eisen H (1984) Synergistic protection
by specific antibodies and interferon against infection by Trypanosoma cruzi in
vitro. Eur J Immunol 14: 930–935.
9. de Titto EH, Cardoni RL (1983) Trypanosoma cruzi: parasite-induced release of
lysosomal enzymes by human polymorphonuclear leukocytes. Exp Parasitol 56:
247–254.
10. Umekita LF, Carneiro SM, Sesso A, Mota I (1999) One fate of bloodstream
trypomastigote forms of Trypanosoma cruzi after immune clearance: an
ultrastructural study. J Parasitol 85: 867–872.
11. Umekita LF, Takehara HA, Mota I (1988) Role of the antibody Fc in the
immune clearance of Trypanosoma cruzi. Immunol Lett 17: 85–89.
12. Mota I, Umekita LF (1989) The effect of C3 depletion on the clearance of
Trypanosoma cruzi induced by IgG antibodies. Immunol Lett 21: 223–225.
13. Sardinha LR, Elias RM, Mosca T, Bastos KR, Marinho CR, et al. (2006)
Contribution of NK, NK T, gammadelta T, and alphabeta T cells to the gamma
interferon response required for liver protection against Trypanosoma cruzi.
Infect Immun 74: 2031–2042.
14. Crispe IN (1996) Isolation of mouse intrahepatic lymphocytes. Current Protocols
in Immunology 3: 22–28.
15. Garcia IE, Lima MR, Marinho CR, Kipnis TL, Furtado GC, et al. (1997) Role
of membrane-bound IgM in Trypanosoma cruzi evasion from immune
clearance. J Parasitol 83: 230–233.
16. Marinho CR, D’Imperio Lima MR, Grisotto MG, Alvarez JM (1999) Influence
of acute-phase parasite load on pathology, parasitism, and activation of the
immune system at the late chronic phase of Chagas’ disease. Infect Immun 67:
308–318.
17. Biermann H, Pietz B, Dreier R, Schmid KW, Sorg C, et al. (1999) Murine
leukocytes with ring-shaped nuclei include granulocytes, monocytes, and their
precursors. J Leukoc Biol 65: 217–231.
18. Ziegler SF, Levin SD, Johnson L, Copeland NG, Gilbert DJ, et al. (1994) The
mouse CD69 gene. Structure, expression, and mapping to the NK gene
complex. J Immunol 152: 1228–1236.
19. Minami Y, Kono T, Miyazaki T, Taniguchi T (1993) The IL-2 receptor complex:
its structure, function, and target genes. Annu Rev Immunol 11: 245–268.
20. Kennedy MK, Park LS (1996) Characterization of interleukin-15 (IL-15) and the
IL-15 receptor complex. J Clin Immunol 16: 134–143.
21. Turka LA, Walsh PT (2008) IL-2 signaling and CD4+ CD25+ Foxp3+
regulatory T cells. Front Biosci 13: 1440–1446.
22. Gazzinelli RT, Oswald IP, Hieny S, James SL, Sher A (1992) The microbicidal
activity of interferon-gamma-treated macrophages against Trypanosoma cruzi
involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhib-
itable by interleukin-10 and transforming growth factor-beta. Eur J Immunol 22:
2501–2506.
23. Laucella SA, Postan M, Martin D, Hubby Fralish B, Albareda MC, et al. (2004)
Frequency of interferon- gamma -producing T cells specific for Trypanosoma
cruzi inversely correlates with disease severity in chronic human Chagas disease.
J Infect Dis 189: 909–918. Epub 2004 Feb 2017.
24. Plata F, Garcia-Pons F, Wietzerbin J (1987) Immune resistance to Trypanosoma
cruzi: synergy of specific antibodies and recombinant interferon gamma in vivo.
Ann Inst Pasteur Immunol 138: 397–415.
25. Umekita LF, Mota I (2000) How are antibodies involved in the protective
mechanism of susceptible mice infected with T. cruzi? Braz J Med Biol Res 33:
253–258.
26. Surh CD, Sprent J (2008) Homeostasis of naive and memory T cells. Immunity
29: 848–862.
Liver Response to T. cruzi Challenge
www.plosntds.org 9 January 2010 | Volume 4 | Issue 1 | e578
27. Higuchi MD, Ries MM, Aiello VD, Benvenuti LA, Gutierrez PS, et al. (1997)
Association of an increase in CD8+ T cells with the presence of Trypanosoma
cruzi antigens in chronic, human, chagasic myocarditis. Am J Trop Med Hyg
56: 485–489.
28. Sun J, Tarleton RL (1993) Predominance of CD8+ T lymphocytes in the
inflammatory lesions of mice with acute Trypanosoma cruzi infection. Am J Trop
Med Hyg 48: 161–169.
29. Reis DD, Jones EM, Tostes S Jr, Lopes ER, Gazzinelli G, et al. (1993)
Characterization of inflammatory infiltrates in chronic chagasic myocardial
lesions: presence of tumor necrosis factor-alpha+ cells and dominance of
granzyme A+, CD8+ lymphocytes. Am J Trop Med Hyg 48: 637–644.
30. Grisotto MG, D’Imperio Lima MR, Marinho CR, Tadokoro CE,
Abrahamsohn IA, et al. (2001) Most parasite-specific CD8+ cells in
Trypanosoma cruzi-infected chronic mice are down-regulated for T-cell
receptor-alphabeta and CD8 molecules. Immunology 102: 209–217.
31. Martin DL, Tarleton RL (2005) Antigen-specific T cells maintain an effector
memory phenotype during persistent Trypanosoma cruzi infection. J Immunol
174: 1594–1601.
32. Bixby LM, Tarleton RL (2008) Stable CD8+ T cell memory during persistent
Trypanosoma cruzi infection. J Immunol 181: 2644–2650.
33. Alcantara A, Brener Z (1978) The in vitro interaction of Trypanosoma cruzi
bloodstream forms and mouse peritoneal macrophages. Acta Trop 35: 209–219.
34. Marinho CR, Nunez-Apaza LN, Martins-Santos R, Bastos KR, Bombeiro AL,
et al. (2007) IFN-gamma, but not nitric oxide or specific IgG, is essential for the
in vivo control of low-virulence Sylvio X10/4 Trypanosoma cruzi parasites.
Scand J Immunol 66: 297–308.
Liver Response to T. cruzi Challenge
www.plosntds.org 10 January 2010 | Volume 4 | Issue 1 | e578
